Groen, Jesse V. http://orcid.org/0000-0002-2438-4665
,
Douwes, Tom A.
van Eycken, Elizabeth
van der Geest, Lydia G. M.
Johannesen, Tom B.
Besselink, Marc G.
Koerkamp, Bas Groot
Wilmink, Johanna W.
Bonsing, Bert A.
Portielje, Johanna E. A.
van de Velde, Cornelus J. H.
Bastiaannet, Esther
Mieog, J. Sven D.
Funding for this research was provided by:
Bas Mulder Award from the Alpe d'HuZes foundation/Dutch Cancer Society (UL2015-7665)
Article History
Received: 5 January 2020
First Online: 9 May 2020
Disclosure
: Johanna W. Wilmink has received research funding from Servier, Halozyme, Novartis, Celgene, Astra Zeneca, Pfizer, Roche, Amgen, and Merck, and has served in a consulting or advisory role for Shire, Servier, and Celgene. The authors declare no conflicts of interest.
: The Medical Ethics Committee of the Leiden University Medical Center waived the need for informed consent due to the use of anonymous data. This study was performed in accordance with the Declaration of Helsinki.
: Not applicable.